ABSTRACT -Background -Vitamin D is known for its immunomodulatory, anti-inflammatory and antifibrotic properties, which are quite relevant in the pathogenesis and treatment of many causes of chronic liver disease. Objective -This study aimed to evaluate the association between serum vitamin D levels and the histopathological findings in patients with chronic hepatitis C virus infection. Methods -Cross-sectional study composed of patients with chronic hepatitis C. All patients underwent vitamin D 25 dosage and anthropometric data analysis. Liver biopsy was performed in a maximum 36-month period before inclusion in the study. Results -Of the 74 patients included in the study, 45 (60.8%) were women, mean age was 57.03±9.24 years, and 63 (85.1%) were white. No association was observed between the serum levels of vitamin D and inflammatory activity (P=0.699) nor with the degree of liver fibrosis (P=0.269). Conclusion -In this study, no association was observed between vitamin D and inflammatory activity, as well as the degree of liver fibrosis, in patients with chronic hepatitis C.
INTRODUCTION
Vitamin D has immunomodulatory, anti-inflammatory and antifibrotic properties, which are relevant in the treatment of many causes of chronic liver disease (12) . Vitamin D deficiency has been observed in most patients with chronic liver disease (1, 7) , regardless of the liver disease etiology (16, 22) . An inversely proportional relationship has been described between vitamin D serum levels and liver fibrosis and response to antiviral treatment with interferon and ribavirin, as well (20) . This study aimed to evaluate the association between vitamin D serum levels and inflammatory activity and degree of liver fibrosis in patients with chronic hepatitis C virus (HCV) infection.
METHODS
A cross-sectional study was developed in a convenience sample composed of patients with chronic HCV infection, with or without cirrhosis, between July 2012 and May 2013.
Seventy-four patients were consecutively included, considering the following: age 18 and over, chronic HCV infection, defined by positive anti-HCV serological test and confirmation of viremia by RNA-HCV. All patients underwent liver biopsy in a maximum 36-month period prior to the inclusion in the study. Patients must not have been under HCV treatment.
Patients with current or previous alcohol abuse problems
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(80g/ day) (19) and coinfected by the hepatitis B (HBV) and/or human immunodeficiency viruses (HIV) were excluded from the study.
No patients were under vitamin D supplementation in the present or in the past. Vitamin D 25 serum concentration was evaluated in all patients by electrochemiluminescence method, using Roche Diagnostics Elecsys analyzer (Switzerland). To evaluate the vitamin D levels, the cutoff was established according to the Endocrine Society Clinical Practice Guideline: deficiency ≤20 ng/ mL; insufficiency 21-29 ng/mL and sufficiency ≥30 ng/mL (11) . Age was analyzed using percentiles (p25∕p50∕p75). The following anthropometric data were evaluated: weight, height and body mass index (BMI), calculated by the formula weight/height² (25) . Patients were not under nutritional monitoring.
Anti-HCV antibodies were detected by ELISA III test, in accordance with manufacturing instructions (Abbott Axsym System, N. Chicago/IL, EUA), followed by real-time polymerase chain reaction (PCR).
Liver biopsy was performed as part of the clinical evaluation protocol to assess HCV treatment indication, using Metavir score (3) for staging. The presence of cirrhosis was evaluated by clinical laboratory methods, image and histopathological analysis, whenever necessary.
This research was submitted and approved by the local Ethics Committee (number 3676/11) and presents minimum risk to the patients. All patients signed the Informed Consent in order to take part in the study. The quantitative variables are presented as mean and standard deviation. The qualitative variables are presented as frequency and percentage. The association between the continuous and ordinal variables with the vitamin D serum levels was evaluated by Spearman's correlation coefficient (r s ). ANOVA and Chi-Squared test were used to verify the association when vitamin D serum levels was categorized. The significance level assumed was 5%.
RESULTS
Seventy-four patients with HCV were included in the study; 45 (60.8%) were women; mean age was 57.0±9.2 years and 63 (85.1%) were white.
Significant fibrosis (F3-F4) was observed in 36 (48.7%) patients; moderate/severe inflammatory activity was found in 38 (51.4%) patients (Table 1) .
Nine (12.2%) patients presented deficiency of vitamin D levels (below 20 ng/mL). When age was evaluated considering the cutoffs for vitamin D levels (sufficiency, insufficiency and deficiency), a mean age of 55.65±9.24 years in those with sufficiency, 59.76±8.57 years in those with insufficiency and a mean age of 59.22±9.88 years in those with deficiency (P=0.217) was observed.
There was no statistically significant differences between the mean vitamin D serum levels and different inflammatory activity or hepatic fibrosis degrees (P=0.700 and P=0.468, respectively). Moreover, no association between vitamin D serum levels and inflammatory activity (r s =0.099; P=0.416), or the degree of liver fibrosis (r s =-0.015; P=0.901) was observed.
Regarding the cutoffs of vitamin D levels (sufficiency, insufficiency and deficiency) there was no association with the inflammatory activity or the hepatic fibrosis degrees (Table 1) .
DISCUSSION
No association between the vitamin D serum levels and the different degrees of inflammatory activity or liver fibrosis was found in this study. Some studies examined the relationship between the vitamin D serum level and the progression of the disease in patients with chronic hepatitis C (5, 10, 12) , but this is a controversial issue. It has been suggested that HCV reduces the production of 7-dehydrocholesterol, the precursor of endogenous vitamin D. Most patients presented low vitamin D levels, suggesting that HCV depresses serum levels and changes the lipid metabolism (6) . Vitamin D deficiency is closely related to the severity of some chronic liver disease (1, 2, 7, 17, 23) . Vitamin D anti-inflammatory and modulating properties could impact on disease progression especially on HCV chronic liver disease (12) . Some authors observed that vitamin D might have an impact on other outcomes and in the response to the treatment of patients with chronic hepatitis C (8, 18, 21, 26) . In the present study, 9 (12.2%) patients presented was observed deficiency. Similar results have been shown in the literature (9) in the population with HCV, although some reports present a high index of vitamin D deficiency/insufficiency.
A recent study (9) showed an inverse relationship between vitamin D levels and viral load, liver fibrosis and treatment outcomes, supporting the hypothesis that the improvement of vitamin D status may have considerable potential to amend the host defense against HCV infection and response to therapy.
An independent association between low vitamin D serum level and higher degree of inflammatory activity has been suggested (4, 13) . A probable explanation for the association between lower vitamin D levels and lower inflammatory activity in the liver would be the decrease of 25-hydroxylase activity, promoting decrease in vitamin D hydroxylation activity and, hence, lower serum levels (13) . However, this association was not observed in this study, corroborating Petta et al.'s findings (20) , putting in question this potential mechanism. Some studies show that vitamin D serum levels are inversely related to liver fibrosis, showing a relationship between the anti-inflammatory effects (10, 14, 20) . Thus, vitamin D deficiency could contribute to a (5) . On the other hand, Kitson et al. (13) and Bitetto et al. (4) did not find association between vitamin D serum levels and the degree of liver fibrosis in their studies, in which the contribuiting factors were not clear, with chances of being racial, genetic or methodological differences used in vitamin D analysis.
It should be questioned if vitamin D deficiency increases with age and the patients included in the present study should be quite young to assess this relationship. Vitamin D concentration was evaluated in individuals in the city of São Paulo belonging to different age groups (15) . A total of 591 individuals were included. The authors hypothesized that there would be cyclic patterns for the vitamin D and the UV radiation values that repeat every 12 months. They concluded that there was seasonal variation in the vitamin D concentration for all the groups studied; however, the amplitude of the variation was higher for the groups of young and physically active people, possibly due to the higher level of sunlight exposure for these groups. The lowest vitamin D concentration was detected in the spring. In the present study, however, this variable was analyzed and there was no association between age and vitamin D level when we considered the cutoffs for sunny countries established by Holick et al. (11) . The fact that this study does not present data on the potential confounders that may influence vitamin D serum levels (sunlight exposure, use of medications or osteoporosis prevalence) can be considered as a limiting factor, although all patients collected the blood in the same season of the year.
Some authors reported that some drugs used for diabetes, for reducing cholesterol or diuretics may interfere lowering serum levels of vitamin D (24) . This may be an interesting observation, however, this was not evaluated in the present study.
In conclusion, there was no association between vitamin D serum levels and inflammatory activity or the degree of liver fibrosis in the patients with chronic HCV infection.
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